Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Denosumab (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 11 May 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 11 May 2016 Status changed from recruiting to active, no longer recruiting.
- 04 Mar 2015 Planned End Date changed from 1 Jan 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.